Translational research key to realising value of university IP, says UCL biopharma chief
Dr Richard Fagan of University College London Business tells IAM about the process of turning patents for early-stage research into investable assets
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10